Nektar Therapeutics Other Comprehensive Income (Loss), Net of Tax
Nektar Therapeutics (NKTR) reported Other Comprehensive Income (Loss), Net of Tax of -$722.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- Nektar Therapeutics other comprehensive income (loss), net of tax for the quarter ending 2026-06-30 was -$722.00K.
- Nektar Therapeutics other comprehensive income (loss), net of tax for the quarter ending 2026-03-31 was -$1.05M.
- Nektar Therapeutics other comprehensive income (loss), net of tax for the quarter ending 2025-12-31 was -$39.00K.
- Nektar Therapeutics other comprehensive income (loss), net of tax for the quarter ending 2025-09-30 was $70.00K, a 91.76% decline year-over-year.
- Nektar Therapeutics other comprehensive income (loss), net of tax for fiscal 2025 was -$44.00K.
- Nektar Therapeutics other comprehensive income (loss), net of tax for fiscal 2024 was -$19.00K, a 100.27% decline from fiscal 2023.
- Nektar Therapeutics other comprehensive income (loss), net of tax for fiscal 2023 was $6.99M.
- Nektar Therapeutics other comprehensive income (loss), net of tax for fiscal 2022 was -$2.75M.
| Period end | Other Comprehensive Income (Loss), Net of Tax 3 month | Other Comprehensive Income (Loss), Net of Tax 3 month as first filed | Other Comprehensive Income (Loss), Net of Tax 6 month | Other Comprehensive Income (Loss), Net of Tax 9 month | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$722.00K 10-Q · filed 2026-08-14 | -$1.77M 10-Q · filed 2026-08-14 | -$1.81M derived: sum of 3 quarters · filed 2026-08-14 | -$1.74M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | -$1.05M 10-Q · filed 2026-05-08 | -$1.09M derived: sum of 2 quarters · filed 2026-05-08 | -$1.02M derived: sum of 3 quarters · filed 2026-05-08 | -$1.07M derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-12-31 | -$39.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $31.00K derived: sum of 2 quarters · filed 2026-03-13 | -$22.00K derived: sum of 3 quarters · filed 2026-08-14 | -$44.00K 10-K · filed 2026-03-13 | |
| 2025-09-30 | $70.00K 10-Q · filed 2025-11-07 | $17.00K derived: sum of 2 quarters · filed 2026-08-14 | -$5.00K 10-Q · filed 2025-11-07 | -$299.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-06-30 | -$53.00K 10-Q · filed 2026-08-14 | -$75.00K 10-Q · filed 2026-08-14 | -$369.00K derived: sum of 3 quarters · filed 2026-08-14 | $480.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | -$22.00K 10-Q · filed 2026-05-08 | -$316.00K derived: sum of 2 quarters · filed 2026-05-08 | $533.00K derived: sum of 3 quarters · filed 2026-05-08 | $442.00K derived: sum of 4 quarters · filed 2026-05-08 | |
| 2024-12-31 | -$294.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | $555.00K derived: sum of 2 quarters · filed 2026-03-13 | $464.00K derived: sum of 3 quarters · filed 2026-03-13 | -$19.00K 10-K · filed 2026-03-13 | |
| 2024-09-30 | $849.00K 10-Q · filed 2025-11-07 | $758.00K derived: sum of 2 quarters · filed 2025-11-07 | $275.00K 10-Q · filed 2025-11-07 | $6.71M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | -$91.00K 10-Q · filed 2025-08-08 | -$574.00K 10-Q · filed 2025-08-08 | $5.86M derived: sum of 3 quarters · filed 2025-08-08 | $5.96M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | -$483.00K 10-Q · filed 2025-05-09 | $5.95M derived: sum of 2 quarters · filed 2025-05-09 | $6.05M derived: sum of 3 quarters · filed 2025-05-09 | $5.28M derived: sum of 4 quarters · filed 2025-05-09 | |
| 2023-12-31 | $6.43M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-14 | $6.53M derived: sum of 2 quarters · filed 2025-03-14 | $5.76M derived: sum of 3 quarters · filed 2025-03-14 | $6.99M 10-K · filed 2025-03-14 | |
| 2023-09-30 | $98.00K 10-Q · filed 2024-11-08 | -$671.00K derived: sum of 2 quarters · filed 2024-11-08 | $555.00K 10-Q · filed 2024-11-08 | $1.82M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$769.00K 10-Q · filed 2024-08-09 | $457.00K 10-Q · filed 2024-08-09 | $1.72M derived: sum of 3 quarters · filed 2024-08-09 | $1.74M derived: sum of 4 quarters · filed 2024-08-09 | |
| 2023-03-31 | $1.23M 10-Q · filed 2024-05-10 | $2.49M derived: sum of 2 quarters · filed 2024-05-10 | $2.51M derived: sum of 3 quarters · filed 2024-05-10 | $851.00K derived: sum of 4 quarters · filed 2024-05-10 | |
| 2022-12-31 | $1.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | $1.28M derived: sum of 2 quarters · filed 2024-03-05 | -$375.00K derived: sum of 3 quarters · filed 2024-03-05 | -$2.75M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $22.00K 10-Q · filed 2023-11-08 | -$1.64M derived: sum of 2 quarters · filed 2023-11-08 | -$4.01M 10-Q · filed 2023-11-08 | -$4.61M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-06-30 | -$1.66M 10-Q · filed 2023-08-09 | -$4.03M 10-Q · filed 2023-08-09 | -$4.63M derived: sum of 3 quarters · filed 2024-03-05 | -$4.79M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2022-03-31 | -$2.38M 10-Q · filed 2023-05-10 | -$2.97M derived: sum of 2 quarters · filed 2024-03-05 | -$3.13M derived: sum of 3 quarters · filed 2024-03-05 | -$3.41M derived: sum of 4 quarters · filed 2024-03-05 | |
| 2021-12-31 | -$594.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -$757.00K derived: sum of 2 quarters · filed 2024-03-05 | -$1.04M derived: sum of 3 quarters · filed 2024-03-05 | -$1.86M 10-K · filed 2024-03-05 | |
| 2021-09-30 | -$163.00K 10-Q · filed 2022-11-04 | -$442.00K derived: sum of 2 quarters · filed 2022-11-04 | -$1.27M 10-Q · filed 2022-11-04 | -$2.48M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-06-30 | -$279.00K 10-Q · filed 2022-08-05 | -$1.10M 10-Q · filed 2022-08-05 | -$2.32M derived: sum of 3 quarters · filed 2023-02-28 | -$4.12M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2021-03-31 | -$826.00K 10-Q · filed 2022-05-06 | -$2.04M derived: sum of 2 quarters · filed 2023-02-28 | -$3.84M derived: sum of 3 quarters · filed 2023-02-28 | $3.76M derived: sum of 4 quarters · filed 2023-02-28 | |
| 2020-12-31 | -$1.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$3.01M derived: sum of 2 quarters · filed 2023-02-28 | $4.58M derived: sum of 3 quarters · filed 2023-02-28 | -$1.29M 10-K · filed 2023-02-28 | |
| 2020-09-30 | -$1.79M 10-Q · filed 2021-11-05 | $5.80M derived: sum of 2 quarters · filed 2021-11-05 | -$75.00K 10-Q · filed 2021-11-05 | -$1.17M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-06-30 | $7.59M 10-Q · filed 2021-08-06 | $1.72M 10-Q · filed 2021-08-06 | $627.00K derived: sum of 3 quarters · filed 2022-03-01 | $6.00K derived: sum of 4 quarters · filed 2022-03-01 | |
| 2020-03-31 | -$5.87M 10-Q · filed 2021-05-07 | -$6.96M derived: sum of 2 quarters · filed 2022-03-01 | -$7.59M derived: sum of 3 quarters · filed 2022-03-01 | -$5.28M derived: sum of 4 quarters · filed 2022-03-01 | |
| 2019-12-31 | -$1.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$1.71M derived: sum of 2 quarters · filed 2022-03-01 | $591.00K derived: sum of 3 quarters · filed 2022-03-01 | $5.31M 10-K · filed 2022-03-01 | |
| 2019-09-30 | -$621.00K 10-Q · filed 2020-11-06 | -$398.00K 10-Q · filed 2019-11-07 | $1.68M derived: sum of 2 quarters · filed 2020-11-06 | $6.40M 10-Q · filed 2020-11-06 | |
| 2019-06-30 | $2.31M 10-Q · filed 2020-08-07 | $1.93M 10-Q · filed 2019-08-09 | $7.03M 10-Q · filed 2020-08-07 | ||
| 2019-03-31 | $4.72M 10-Q · filed 2020-05-08 | $3.60M 10-Q · filed 2019-05-09 | |||
| 2018-12-31 | -$4.21M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$1.38M 10-Q · filed 2019-11-07 | -$2.58M derived: sum of 2 quarters · filed 2019-11-07 | -$3.27M derived: sum of 3 quarters · filed 2019-11-07 | ||
| 2018-06-30 | -$1.21M 10-Q · filed 2019-11-07 | -$1.89M derived: sum of 2 quarters · filed 2019-11-07 | |||
| 2018-03-31 | -$685.00K 10-Q · filed 2019-11-07 | ||||
| 2017-12-31 | $252.00K 10-K · filed 2020-02-28 | ||||
| 2016-12-31 | -$193.00K 10-K · filed 2019-03-01 | ||||
| 2015-12-31 | -$603.00K 10-K · filed 2018-03-01 | ||||
| 2014-12-31 | -$386.00K 10-K · filed 2017-03-01 | ||||
| 2013-12-31 | -$824.00K 10-K · filed 2016-02-29 | ||||
| 2012-12-31 | $746.00K 10-K · filed 2015-02-26 | ||||
| 2011-12-31 | -$2.07M 10-K · filed 2014-02-27 | ||||
| 2010-12-31 | -$57.00K 10-K · filed 2013-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |